SCHEMBL7712031

SCHEMBL7712031

Cc1c(Cl)ccc(P(=O)(c2ccccc2)c2ccccc2)c1-c1c(P(=O)(c2ccccc2)c2ccccc2)ccc(Cl)c1C

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 5/20 0.38
MAPT P10636 4/20 0.38
POLB P06746 3/20 0.38
KDM4E B2RXH2 3/20 0.38
KMT2A Q03164 5/20 0.36
MEN1 O00255 2/20 0.36
LMNA P02545 1/20 0.36
ALDH1A1 P00352 3/20 0.35
HTT P42858 2/20 0.35
CA2 P00918 1/20 0.33
CA4 P22748 1/20 0.33
CA5A P35218 1/20 0.33
APOBEC3A P31941 1/20 0.33
CASP6 P55212 1/20 0.33
CTDSP1 Q9GZU7 1/20 0.33
APOBEC3G Q9HC16 1/20 0.33
RECQL P46063 1/20 0.33
ESR1 P03372 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7558272 0.88 MAPT (0.38) NPSR1MAPTPOLBKDM4EKMT2A
SCHEMBL2209439 0.79 NPSR1 (0.45) NPSR1MAPTPOLBKDM4EKMT2A
SCHEMBL2211499 0.78 ALDH1A1 (0.41) NPSR1MAPTPOLBKDM4EKMT2A
SCHEMBL28344959 0.72 NPSR1 (0.44) NPSR1MAPTPOLBKDM4EKMT2A
SCHEMBL14020795 0.72 NPSR1 (0.52) NPSR1MAPTPOLBKDM4EKMT2A
SCHEMBL3459141 0.72 NPSR1 (0.41) NPSR1MAPTPOLBKDM4EKMT2A
SCHEMBL9056100 0.72 NPSR1 (0.49) NPSR1MAPTPOLBKDM4EKMT2A
SCHEMBL4846541 0.71 SMN1; SMN2 (0.35) NPSR1MAPTPOLBKDM4EKMT2A
SCHEMBL4846388 0.71 KDM4E (0.31) NPSR1MAPTPOLBKDM4EKMT2A
SCHEMBL4847287 0.71 SMN1; SMN2 (0.33) NPSR1MAPTPOLBKDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6489513-B2 REACTING AROMATIC BROMINE COMPOUND WITH DIPHENYLPHOSPHINIC CHLORIDE IN A MIXTURE OF TETRAHYDROFURAN AND AROMATIC HYDROCARBON TO GIVE A DIPHENYLPHOSPHINE OXIDE, ISOLATING, METALATING; REACTING WITH IODINE, REACTING WITH COPPER BAYER AKTIENGESELLSCHAFT (DE) 2002-12-03 US disclosed
US-20020058814-A1 Process for the preparation of enantiomerically pure (5,5'-dichloro-6,6'-dimethoxy-biphenyl-2,2'-diyl)- bis(diphenylphosphine oxides) LANXESS DEUTSCHLAND GMBH (DE) 2002-05-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020058814-A1 Process for the preparation of enantiomerically pure (5,5'-dichloro-6,6'-dimethoxy-biphenyl-2,2'-diyl)- bis(diphenylphosphine oxides) DDT, HDHD5, DDC NPSR1 3249/4885MAPT 1329/4885POLB 392/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.